MedDay Announces Full Enrollment for MD1003 Phase III

Biotin is an emerging therapy for the treatment of secondary progressive MS.
Post Reply

Post Reply
  • Similar Topics
    Replies
    Views
    Last post
  • Ibudilast phase II successful
    by NHE » 4 months ago » in Drug Pipeline
    1 Replies
    1196 Views
    Last post by Zyklon
    4 months ago